DiaSorin S.p.A. (BIT:DIA)
67.10
+1.60 (2.44%)
May 28, 2026, 4:55 PM CET
DiaSorin Revenue
DiaSorin had revenue of 287.00M EUR in the quarter ending March 31, 2026, a decrease of -8.31%. This brings the company's revenue in the last twelve months to 1.17B, down -3.42% year-over-year. In the year 2025, DiaSorin had annual revenue of 1.20B with 0.81% growth.
Revenue (ttm)
1.17B
Revenue Growth
-3.42%
P/S Ratio
2.97
Revenue / Employee
360.60K
Employees
3,272
Market Cap
3.47B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.20B | 9.63M | 0.81% |
| Dec 31, 2024 | 1.19B | 37.22M | 3.24% |
| Dec 31, 2023 | 1.15B | -212.93M | -15.64% |
| Dec 31, 2022 | 1.36B | 123.49M | 9.98% |
| Dec 31, 2021 | 1.24B | 356.35M | 40.43% |
| Dec 31, 2020 | 881.31M | 174.99M | 24.77% |
| Dec 31, 2019 | 706.32M | 37.12M | 5.55% |
| Dec 31, 2018 | 669.20M | 31.71M | 4.97% |
| Dec 31, 2017 | 637.49M | 68.18M | 11.97% |
| Dec 31, 2016 | 569.31M | 70.13M | 14.05% |
| Dec 31, 2015 | 499.18M | 55.41M | 12.49% |
| Dec 31, 2014 | 443.77M | 8.92M | 2.05% |
| Dec 31, 2013 | 434.85M | 1.09M | 0.25% |
| Dec 31, 2012 | 433.76M | -6.24M | -1.42% |
| Dec 31, 2011 | 440.00M | 35.46M | 8.76% |
| Dec 31, 2010 | 404.55M | 100.42M | 33.02% |
| Dec 31, 2009 | 304.13M | 59.52M | 24.33% |
| Dec 31, 2008 | 244.61M | 42.29M | 20.90% |
| Dec 31, 2007 | 202.32M | 22.57M | 12.55% |
| Dec 31, 2006 | 179.76M | 23.23M | 14.84% |
| Dec 31, 2005 | 156.52M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 2.65B |
| Amplifon | 2.39B |
| Safilo Group | 983.38M |
| EL.En. | 594.84M |
| GPI S.p.A. | 546.18M |
| Garofalo Health Care | 489.26M |
| Philogen | 319.73M |
| Svas Biosana | 141.56M |
DiaSorin News
- 8 days ago - DiaSorin Transcript: Investor Day 2026 - Transcripts
- 8 days ago - DiaSorin Press release: FY 2026 - Filings
- 8 days ago - DiaSorin Slides: FY 2026 - Filings
- 19 days ago - DiaSorin Earnings Call Transcript: Q1 2026 - Transcripts
- 19 days ago - DiaSorin Earnings release: Q1 2026 - Filings
- 19 days ago - DiaSorin Slides: Q1 2026 - Filings
- 4 weeks ago - DiaSorin price target lowered to EUR 62 from EUR 65 at Deutsche Bank - TheFly
- 7 weeks ago - DiaSorin downgraded to Neutral from Buy at UBS - TheFly